Global Contrast Enhanced Ultrasound Market Size Study & Forecast by Product (Equipment, Nanoparticle & Molecule-targeted Microbubbles, Software), Application (Diagnostic, Therapeutic, CVDs, Liver, Kidney, Oncology) and Regional Forecasts 2025-2035

Description

The Global Contrast Enhanced Ultrasound Market is valued approximately at USD 1.58 billion in 2024 and is anticipated to grow at a robust CAGR of 6.10% over the forecast period 2025-2035. Contrast-enhanced ultrasound (CEUS) is a revolutionary imaging technology that leverages microbubbles and nanoparticle agents to enhance the visualization of blood flow and tissue vascularity, thereby improving diagnostic accuracy and enabling more precise therapeutic interventions. Its increasing adoption across diagnostic and therapeutic applications, particularly in oncology, cardiology, and liver and kidney assessments, is driving market expansion globally. Moreover, advancements in software integration and real-time imaging capabilities are significantly augmenting the clinical utility of CEUS, thereby creating substantial growth opportunities for key market players.

The surge in the prevalence of chronic diseases such as cardiovascular disorders, liver and kidney abnormalities, and various cancers is directly fueling the demand for contrast-enhanced ultrasound procedures. Hospitals, specialized clinics, and ambulatory surgical centers (ASCs) are increasingly investing in advanced CEUS equipment and related technologies to enhance diagnostic accuracy while reducing patient exposure to ionizing radiation. Technological innovations, including nanoparticle and molecule-targeted microbubbles, have further expanded the clinical applications of CEUS, offering higher sensitivity and specificity. Nevertheless, market growth may be moderated by the high cost of equipment and regulatory complexities associated with contrast agent approvals, alongside competition from alternative imaging modalities such as MRI and CT.

Regionally, North America dominated the CEUS market in 2025, driven by the well-established healthcare infrastructure, widespread adoption of advanced imaging technologies, and high incidence of cardiovascular diseases and cancer. Europe follows closely, with strong growth attributed to increased healthcare expenditure, government initiatives promoting early disease diagnosis, and growing awareness of non-invasive imaging technologies. The Asia Pacific region is projected to witness the fastest growth during the forecast period, propelled by rising healthcare demand from population growth, expanding hospital networks, and increased investment in medical imaging technologies across countries like China and India. Additionally, Latin America and the Middle East & Africa are anticipated to present lucrative opportunities due to improving healthcare infrastructure and growing adoption of advanced diagnostic modalities.

Major market players included in this report are:

GE Healthcare
Siemens Healthineers
Bracco Imaging
Lantheus Holdings, Inc.
Philips Healthcare
Fujifilm Holdings Corporation
Samsung Medison
Guerbet Group
SonoVue
Analogic Corporation
Hitachi Medical Systems
Mindray Medical International
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Acusphere, Inc.
Canon Medical Systems Corporation

Global Contrast Enhanced Ultrasound Market Report Scope:

Historical Data - 2023, 2024
Base Year for Estimation - 2024
Forecast period - 2025-2035
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

By Product:

Equipment
Nanoparticle & Molecule-targeted Microbubbles
Software

By Application:

Diagnostic
Therapeutic
Cardiovascular Diseases (CVDs)
Liver
Kidney
Oncology

By End User:

Hospitals
Clinics
Ambulatory Surgical Centers (ASCs)

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
RoE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa

Key Takeaways:

Market Estimates & Forecast for 10 years from 2025 to 2035.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Contrast Enhanced Ultrasound Market Report Scope & Methodology

1.1. Research Objective
1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings

Chapter 3. Global Contrast Enhanced Ultrasound Market Forces Analysis

3.1. Market Forces Shaping The Global Contrast Enhanced Ultrasound Market (2024-2035)
3.2. Drivers
- 3.2.1. Rising prevalence of cardiovascular diseases, oncology cases and chronic liver/kidney disorders driving diagnostic demand
- 3.2.2. Technological advancements - nanoparticle & molecule-targeted microbubbles and software/AI integration enhancing clinical utility
3.3. Restraints
- 3.3.1. High capital expenditure for advanced CEUS equipment and constrained reimbursement policies in certain regions
- 3.3.2. Regulatory complexities for contrast agent approvals and competition from MRI/CT modalities limiting adoption
3.4. Opportunities
- 3.4.1. Rapid healthcare expansion and increasing diagnostic investments in Asia Pacific and other emerging markets
- 3.4.2. Growth in theranostic applications and portable/point-of-care ultrasound solutions integrated with CEUS agents

Chapter 4. Global Contrast Enhanced Ultrasound Industry Analysis

4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Contrast Enhanced Ultrasound Market Size & Forecasts by Product 2025-2035

5.1. Market Overview
5.2. Global Contrast Enhanced Ultrasound Market Performance - Potential Analysis (2025)
5.3. Equipment
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market size analysis, by region, 2025-2035
5.4. Nanoparticle & Molecule-targeted Microbubbles
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market size analysis, by region, 2025-2035
5.5. Software
- 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.5.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Contrast Enhanced Ultrasound Market Size & Forecasts by Application 2025-2035

6.1. Market Overview
6.2. Global Contrast Enhanced Ultrasound Market Performance - Potential Analysis (2025)
6.3. Diagnostic
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market size analysis, by region, 2025-2035
6.4. Therapeutic
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035
6.5. Cardiovascular Diseases (CVDs)
- 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.5.2. Market size analysis, by region, 2025-2035
6.6. Liver
- 6.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.6.2. Market size analysis, by region, 2025-2035
6.7. Kidney
- 6.7.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.7.2. Market size analysis, by region, 2025-2035
6.8. Oncology
- 6.8.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.8.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Contrast Enhanced Ultrasound Market Size & Forecasts by Region 2025-2035

7.1. Contrast Enhanced Ultrasound Market, Regional Market Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Contrast Enhanced Ultrasound Market
- 7.3.1. U.S. Contrast Enhanced Ultrasound Market
  - 7.3.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.3.1.2. Application breakdown size & forecasts, 2025-2035
- 7.3.2. Canada Contrast Enhanced Ultrasound Market
  - 7.3.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.3.2.2. Application breakdown size & forecasts, 2025-2035
7.4. Europe Contrast Enhanced Ultrasound Market
- 7.4.1. UK Contrast Enhanced Ultrasound Market
  - 7.4.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.1.2. Application breakdown size & forecasts, 2025-2035
- 7.4.2. Germany Contrast Enhanced Ultrasound Market
  - 7.4.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.2.2. Application breakdown size & forecasts, 2025-2035
- 7.4.3. France Contrast Enhanced Ultrasound Market
  - 7.4.3.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.3.2. Application breakdown size & forecasts, 2025-2035
- 7.4.4. Spain Contrast Enhanced Ultrasound Market
  - 7.4.4.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.4.2. Application breakdown size & forecasts, 2025-2035
- 7.4.5. Italy Contrast Enhanced Ultrasound Market
  - 7.4.5.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.5.2. Application breakdown size & forecasts, 2025-2035
- 7.4.6. Rest of Europe Contrast Enhanced Ultrasound Market
  - 7.4.6.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.6.2. Application breakdown size & forecasts, 2025-2035
7.5. Asia Pacific Contrast Enhanced Ultrasound Market
- 7.5.1. China Contrast Enhanced Ultrasound Market
  - 7.5.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.1.2. Application breakdown size & forecasts, 2025-2035
- 7.5.2. India Contrast Enhanced Ultrasound Market
  - 7.5.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.2.2. Application breakdown size & forecasts, 2025-2035
- 7.5.3. Japan Contrast Enhanced Ultrasound Market
  - 7.5.3.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.3.2. Application breakdown size & forecasts, 2025-2035
- 7.5.4. Australia Contrast Enhanced Ultrasound Market
  - 7.5.4.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.4.2. Application breakdown size & forecasts, 2025-2035
- 7.5.5. South Korea Contrast Enhanced Ultrasound Market
  - 7.5.5.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.5.2. Application breakdown size & forecasts, 2025-2035
- 7.5.6. Rest of APAC Contrast Enhanced Ultrasound Market
  - 7.5.6.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.6.2. Application breakdown size & forecasts, 2025-2035
7.6. Latin America Contrast Enhanced Ultrasound Market
- 7.6.1. Brazil Contrast Enhanced Ultrasound Market
  - 7.6.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.6.1.2. Application breakdown size & forecasts, 2025-2035
- 7.6.2. Mexico Contrast Enhanced Ultrasound Market
  - 7.6.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.6.2.2. Application breakdown size & forecasts, 2025-2035
7.7. Middle East and Africa Contrast Enhanced Ultrasound Market
- 7.7.1. UAE Contrast Enhanced Ultrasound Market
  - 7.7.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.7.1.2. Application breakdown size & forecasts, 2025-2035
- 7.7.2. Saudi Arabia (KSA) Contrast Enhanced Ultrasound Market
  - 7.7.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.7.2.2. Application breakdown size & forecasts, 2025-2035
- 7.7.3. South Africa Contrast Enhanced Ultrasound Market
  - 7.7.3.1. Product breakdown size & forecasts, 2025-2035
  - 7.7.3.2. Application breakdown size & forecasts, 2025-2035

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. GE Healthcare
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Financial Performance (Subject to Data Availability)
- 8.2.5. Product/Services Port
- 8.2.6. Recent Development
- 8.2.7. Market Strategies
- 8.2.8. SWOT Analysis
8.3. Siemens Healthineers
8.4. Philips Healthcare
8.5. Canon Medical Systems Corporation
8.6. Fujifilm Holdings Corporation
8.7. Bracco Imaging
8.8. Lantheus Holdings, Inc.
8.9. Guerbet Group
8.10. Samsung Medison
8.11. Hitachi Medical Systems
8.12. Mindray Medical International
8.13. Analogic Corporation
8.14. Acusphere, Inc.
8.15. Additional Key Players / Emerging Vendors